News
High Purity New England Introduces Defined Tubing Routing for Single-Use Facilities
High Purity New England (HPNE), a leading supplier of biopharma equipment and process systems for the Biopharma industry announces its new line of Defined Tubing Routing (DTR), a flexible tubing support system targeted for single-use biopharmaceutical manufacturing. This modular...
News
China’s Experimental COVID-19 Vaccine Appears Safe In Early Trials Study
COVID-19 Vaccine: In a Phase 1 trial of 191 healthy participants aged between 18 and 59, vaccination with the group's experimental shot showed no severe adverse reactions, its COVID-19 Vaccine: In a Phase 1 trial of 191 healthy participants...
News
Second UK Covid-19 vaccine manufacturing site gets MHRA approval
The second of two GMP manufacturing sites for the UK’s specialist vaccines manufacturing equipment has been approved by the Medicines & Healthcare products Regulatory Agency (MHRA).
Announced by the Vaccines Manufacturing and Innovation Centre (VMIC), the new site means there...
News
Zydus Cadila Covid vaccine likely to be ready by March 2021
Phase-2 trials of Zydus Cadila's indigenous vaccine ZyCoV-D is moving in the right direction and the data will be available by the end of November and the vaccine is likely to be available by March 2021, said Pankaj R...
Drug Research
iBio Enters into Agreement with Safi Biosolutions to Develop Growth Factors and Cytokines Using the FastPharming System
iBio, Inc., a biotech innovator and biologics contract manufacturing organization, announced that it has entered into a Master Services Agreement (“MSA”) with Boston-based Safi Biosolutions, Inc. (“Safi”) to evaluate iBio’s FastPharming® System for the expression of key proteins to...
Clinical Trials
Kodiak begins three phase 3 studies of anti-VEGF antibody biopolymer conjugate, KSI-301 to treat DME and macular edema due to retinal vein occlusion
Kodiak Sciences Inc., a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced that the first patients have been treated in the randomized, double-masked GLEAM, GLIMMER and BEACON studies, three pivotal...
News
Blue Dart strengthens temperature controlled logistics solution to fight against COVID-19
Blue Dart, India’s leading express logistics service provider and part of the Deutsche Post DHL Group (DPDHL) with its commitment to help improve the supply chain and ensure timely medical provisions is ramping up its infrastructure with its pre-existing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















